Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety, tolerability, drug interactions
with buprenorphine-naloxone, and effectiveness lemborexant when used to treat Opioid Use
Disorder.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Lemborexant Naloxone